entertainment -WSS

entertainment

author：Wikipedia 2025-09-29 23:28:00 - browse：89

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology

WSS

SCOTUS to consider access to abortion pill mifepristone

What PEPFAR has meant on the ground in Ukraine

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

FDA endorses new sterilization method for medical devices

CMS should re

FDA endorses new sterilization method for medical devices

focus

entertainment

explore

Peter Hotez and the public health issue of online harassment

Patients' immediate access to test results puts radiologists in a bind

Dobbs anniversary: the lost opportunity of abortion as health care

Inaction leaves children at risk from dangerous chemotherapy drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

After sickle

Virginia high school admissions case could be legal follow

Pharma patents targeted by Biden in move to slash drug prices

At least 13 dead in Texas as scorching temps continue

What causes osteoarthritis? Researchers study link to brain protein

focus

FDA approves world's first CRISPR

What causes osteoarthritis? Researchers study link to brain protein

CVS is on a mission to consolidate health care. Will it work?

Cardiologists urge adding sexual orientation, gender identity to health records

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

CMS should re

leisure time

leisure time

knowledge

explore